NOV Inc.
Government Contracts & Awards
BASILEA PHARMACEUTICA INTERNATIONAL LTD, ALLSCHWIL: $123M Department of Health and Human Services Contract
$122,501,232NOVA SPACE SOLUTIONS, LLC: THIS COSMIC TASK ORDER IS CREATED FOR FUNDING OF THE COST PLUS INCENTIVE FEE CLIN 9004 OF
$120,016,601Proprietary Tech & Patents
SYSTEM AND METHOD FOR MAINTAINING TTFIELDS DURING BATTERY CHANGES
Dynamically Controlled Treatment Protocols for Autonomous Treatment Systems
METHODS OF TREATMENT OF CANCER WITH ANTIBODY-IL-2 ENGRAFTED PROTEINS
FLUIDIZED BED REACTOR AND METHOD FOR RECOVERING ACTIVE METAL OF LITHIUM SECONDARY BATTERY UTILIZING SAME
ANTICIPATED SATELLITE COVERAGE NOTIFICATIONS
ELECTROMAGNETIC ACTUATOR AND VALVE HAVING THE ELECTROMAGNETIC ACTUATOR
A CELL SURFACE TAG EXCHANGE (CSTE) SYSTEM FOR TRACING AND MANIPULATION OF CELLS DURING RECOMBINASE MEDIATED CASSETTE EXCHANGE INTEGRATION OF NUCLEIC ACID SEQUENCES TO ENGINEERED RECEIVER CELLS
PHARMACEUTICAL COMPOSITION FOR TREATMENT OF CANCER, COMPRISING AN IMMUNE CHECKPOINT INHIBITOR ANTIBODY AND A FUSION PROTEIN COMPRISING AN IL-2 MUTANT AND A CD80 EXTRACELLULAR DOMAIN
CORONAVIRUS VACCINE FORMULATIONS
ROOT BUSHING, WIND TURBINE ROTOR BLADE AND METHOD
Form D Funding
Private Placement
Private Placement
Private Placement
Private Placement
Private Placement
Market Intelligence & News
Senate OKs records access bill as November ballot fight looms
$5,000 in GE Vernova at Its 2024 Low Would Be Worth This Much Now
GE's energy spin-off is still a great long-term play on the booming AI market.
Scott Strazik's GE Vernova Has a $176 Billion Backlog. So Why Did Wall Street Sell the Stock?
There just wasn't room for anything less than perfection. But, there's a "but."
Novo Nordisk Shares Plunge After a Key Trial Fails. Should Investors Buy the Dip?
With the stock near a 5-year low, is it worth a look?
Weight Loss Drug Stocks Slump. What Ozempic Maker Novo Nordisk Said.
Novo Nordisk and Eli Lilly, the firms behind Ozemic, Wegovy and Zepbound, faced selling pressure on Friday.
Senate OKs records access bill as November ballot fight looms
Eli Lilly Stock Has Skyrocketed. Novo Nordisk Has Crashed. 1 Number Explains Why They're Not Even Close Anymore.
The global market for obesity drugs is soaring, yet Lilly has a dominant market share.
Novo Nordisk’s Heart Drug Suffers a Major Setback. What It Means for the Stock.
The Danish drugmaker is striving to diversify beyond its popular weight-loss drugs, but its anti-inflammatory drug candidate faces a challenge.
Novo Nordisk vs Eli Lilly: The Better Buy Before Earnings
Novo Nordisk and Eli Lilly compete in the same blockbuster drug class, yet their 2026 earnings tell dramatically different stories about which company holds the upper hand heading into a pivotal summer of reports and pricing resets.
Weight Loss Drug Stocks Slump Below Key Levels. What Ozempic Maker Said.
Novo Nordisk and Eli Lilly, the firms behind Ozemic, Wegovy and Zepbound, faced selling pressure on Friday.
Congressional Trades in $NOV
No disclosed congressional trades found in $NOV.
Insider Trades (Form 4)
Donadio Marcela E
Chowbey Sanjay
Martinez Patricia
Welborn Robert S.
Key People
Donadio Marcela E
Director
Martinez Patricia
Director
Chowbey Sanjay
Director
Welborn Robert S
Director
Political Giving
$966,472 given to 127 candidates across 500 disclosed contributions (FEC Schedule A).
Lori Trahan
Linda T. Sanchez
Deborah Ross
Kevin Hern
Neal Patrick Dunn, MD, FACS
Susie Lee
Darin McKay LaHood
Earl Leroy Carter
Bill Cassidy
Nicole Malliotakis
George Whitesides
Brad Knott
Katherine M. Clark
Blake Moore
Greg Landsman
John Curtis
Daniel Goldman
Terri A. Sewell
James E Hon Banks
Scott H. Peters
+ 107 more recipients not shown.
Factual Connections
Connections to other companies, executives, and politicians — sourced from disclosed trades, shared officers/directors, and public filings — are a Pro/Alpha feature.
Upgrade to Pro